| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.27 | 0.07 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.07 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |